The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWRES.L Regulatory News (WRES)

  • There is currently no data for WRES

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Debt for Equity Swap Agreement

22 May 2009 15:00

RNS Number : 7370S
Caspian Holdings plc
22 May 2009
 



Caspian Holdings Plc

("Caspian" or the "Company")

22 May 2009

Debt for Equity Swap Agreement with Noteholders and Creditors

 

Further to the Company's announcement of 11 February 2009, the Directors of Caspian have been in discussions with its noteholders and creditors and have now reached an agreement to convert the majority of the Company's outstanding debt to equity including the outstanding loan notes and major creditors owing. The proposed conversion of this debt will be at a price of £0.005 per ordinary share and will result in the issue of 230,423,326 ordinary shares.

Related Party Transactions

Noteholders

Masterman Investments Limited (a company related to Michael Masterman, a director of Caspian) and Beronia Investment PTY LTD (a company related to Byron Pirola, a director of Caspian) will be issued 53,181,506 ordinary shares and 31,908,904 ordinary shares respectively in consideration for their interest in the outstanding loan notes. The shares issued to Masterman Investments Limited and Beronia Investment PTY LTD are therefore classified as related party transactions for the purposes of the AIM Rules. Accordingly the Directors (other than Michael Masterman and Byron Pirola), having consulted with Grant Thornton UK LLP (in its capacity as the Company's nominated adviser), confirm that they are satisfied that the terms of Masterman Investments Limited and Beronia Investment PTY LTD's participation in the conversion are fair and reasonable insofar as the shareholders of the Company are concerned.

Major Creditors

Michael Masterman, a director of Caspian, and Michael Garland, a director of Caspian will be issued 49,442,504 ordinary shares and 10,800,000 ordinary shares respectively in lieu of fees owed in relation to the performance of their duties as directors of the Company for the period from December 2006 to January 2009. The shares issued to Michael Masterman and Michael Garland are therefore classified as related party transactions for the purposes of the AIM Rules. Accordingly the Directors (other than Michael Masterman and Michael Garland), having consulted with Grant Thornton UK LLP (in its capacity as the Company's nominated adviser), confirm that they are satisfied that the terms of Michael Masterman and Michael Garland's participation in the conversion are fair and reasonable insofar as the shareholders of the Company are concerned.

Following this issue of shares, the Company will have 362,072,011 Ordinary Shares of 0.1p in issue assuming that no further shares are issued by the Company in the interim period.

The increase in the authorised capital and the associated share placements as detailed above will be subject to shareholder approval and a circular and notice convening a General Meeting of shareholders will be sent to shareholders shortly. In the event that this reorganisation is not finalised and debt for equity swap is not approved the Company will not be able to meet its obligations when they fall due.

Following the above conversions, Michael Masterman will be interested in 141,694,010, ordinary shares in the Company representing an interest of 39.13% in the total voting rights of the Company. In addition, Michael Masterman is interested in 6,250,000 options over ordinary shares in the Company as follows:

Stock Options Held Option Exercise Price Expiry Date

5,000,000 £0.04 31 December 2010

1,250,000 £0.03 31 December 2010

Following the above conversions, Byron Pirola will be interested in 41,305,904 ordinary shares in the Company representing an interest of 11.41% in the total voting rights of the Company. In addition, Byron Pirola is interested in 3,750,000 options over ordinary shares in the Company as follows:

Stock Options Held Option Exercise Price Expiry Date

2,500,000 £0.04 31 December 2010

1,250,000 £0.03 31 December 2010

Following the above conversions, Michael Garland will be interested in 10,800,000 ordinary shares in the Company representing an interest of 2.98% in the total voting rights of the Company.

Creditors have been supportive as the Company has worked through the proposed restructuring and debt for equity swap with noteholders as indicated above.

With the support of noteholders and creditors, the Company can continue to trade through to June 2009 when the proposed realisation of field equipment will commence. Failure to complete the proposed debt equity swap or actions by creditors would result in the Company not being able to continue to trade.

The Company will continue to update the market as required under the AIM Rules. 

Caspian Holdings Plc

Grant Thornton UK LLP

Hoodless Brennan 

Michael Masterman

Fiona Owen

T: +44 (0) 7791 288381

T: +44 (0) 20 7383 5100

T: +44 (0) 20 7538 1166

www.caspianoil.co.uk 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCATMJTMMATBFL
Date   Source Headline
26th May 20227:00 amRNSCancellation - W Resources plc
25th May 202212:33 pmRNSDelisting from AIM
23rd May 20225:30 pmRNSW Resources
23rd May 20227:00 amRNSDrawdown from BlackRock Additional Loan Facility
25th Apr 20227:02 amRNSResignation of Nomad and Broker
8th Apr 202212:36 pmRNSHolding(s) in Company
5th Apr 20227:40 amRNSStatement re. Suspension
5th Apr 20227:30 amRNSSuspension - W Resources Plc
18th Mar 20227:00 amRNSLa Parrilla Update
2nd Mar 20227:00 amRNSBlackRock Additional US$5.5m Loan Facility
24th Feb 20227:00 amRNSFinance Update
18th Feb 20225:30 pmRNSFinance Update
15th Feb 202211:06 amRNSSecond Price Monitoring Extn
15th Feb 202211:01 amRNSPrice Monitoring Extension
15th Feb 20228:16 amRNSProduction Report and Finance Update
31st Jan 20227:00 amRNSTotal Voting Rights
11th Jan 20228:01 amRNSHolding(s) in Company
5th Jan 20227:00 amRNSLa Parrilla Update and Placing for £0.83m
1st Dec 202110:45 amRNSTotal Voting Rights
15th Nov 20212:12 pmRNSPlacing to Raise £750,000
1st Nov 20217:03 amRNSRégua Awarded Mining Licence and Portugal Update
21st Oct 20217:00 amRNSQ3 2021 Production Report
11th Oct 20217:00 amRNSAppointment of Non-executive Director
11th Oct 20217:00 amRNSBoard Change and Management Update
5th Oct 20215:31 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSHalf-year Report to 30 June 2021
24th Sep 20212:00 pmRNSPrice Monitoring Extension
24th Sep 20217:00 amRNSAtlas Conversion Notice & Total Voting Rights
15th Sep 20217:00 amRNSLa Parrilla Update
13th Sep 20217:00 amRNSAtlas Conversion Notice and Total Voting Rights
31st Aug 202112:00 pmRNSTotal Voting Rights
27th Aug 202111:12 amRNSPDMR Shareholding and Total Voting Rights
9th Aug 20217:00 amRNSLa Parrilla Update
4th Aug 20218:35 amRNSAtlas Conversion Notice and Total Voting Rights
15th Jul 20217:19 amRNSQ2 2021 Production Report
30th Jun 202111:58 amRNSResult of AGM
30th Jun 20217:00 amRNSTotal Voting Rights
28th Jun 20217:00 amRNSHolding(s) in Company
24th Jun 202111:30 amRNSAGM Arrangements
18th Jun 202111:43 amRNSDirector Subscription and additional share issues
16th Jun 20217:00 amRNSLa Parrilla: Completion of the 500,000m3 dam
4th Jun 20217:00 amRNSFinal Results and Notice of AGM
2nd Jun 20217:00 amRNSHolding(s) in Company
2nd Jun 20217:00 amRNSTotal Voting Rights
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:36 pmRNSPrice Monitoring Extension
17th May 20217:00 amRNSPlacing to Raise £2.5m. Total Voting Rights
10th May 20217:00 amRNSExtremadura Government Grant Received
30th Apr 20217:00 amRNSTotal Voting Rights
23rd Apr 20217:00 amRNSLa Parrilla Management Team and Shipments Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.